Literature DB >> 7729661

Prognosis in nonalcoholic steatohepatitis.

A Propst, T Propst, G Judmaier, W Vogel.   

Abstract

Entities:  

Mesh:

Year:  1995        PMID: 7729661     DOI: 10.1016/0016-5085(95)90724-6

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  11 in total

Review 1.  Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame.

Authors:  Samar H Ibrahim; Petra Hirsova; Harmeet Malhi; Gregory J Gores
Journal:  Dig Dis Sci       Date:  2015-12-01       Impact factor: 3.199

Review 2.  Mechanisms of lipotoxicity in NAFLD and clinical implications.

Authors:  Samar H Ibrahim; Rohit Kohli; Gregory J Gores
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-08       Impact factor: 2.839

Review 3.  Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence.

Authors:  Shira Zelber-Sagi; Vlad Ratziu; Ran Oren
Journal:  World J Gastroenterol       Date:  2011-08-07       Impact factor: 5.742

4.  Steatosis and steatohepatitis in postmortem material from Northwestern Greece.

Authors:  Christos-D Zois; Gerasimos-H Baltayiannis; Anna Bekiari; Anna Goussia; Peter Karayiannis; Michalis Doukas; Demetrios Demopoulos; Antigoni Mitsellou; Theodoros Vougiouklakis; Vasiliki Mitsi; Epameinondas-V Tsianos
Journal:  World J Gastroenterol       Date:  2010-08-21       Impact factor: 5.742

Review 5.  Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials.

Authors:  Shira Zelber-Sagi; Justyna Godos; Federico Salomone
Journal:  Therap Adv Gastroenterol       Date:  2016-03-17       Impact factor: 4.409

Review 6.  Role of Silent Information Regulator 1 (SIRT1) in Regulating Oxidative Stress and Inflammation.

Authors:  Vivek Singh; Saba Ubaid
Journal:  Inflammation       Date:  2020-10       Impact factor: 4.092

7.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.

Authors:  Jorge Henao-Mejia; Eran Elinav; Chengcheng Jin; Liming Hao; Wajahat Z Mehal; Till Strowig; Christoph A Thaiss; Andrew L Kau; Stephanie C Eisenbarth; Michael J Jurczak; Joao-Paulo Camporez; Gerald I Shulman; Jeffrey I Gordon; Hal M Hoffman; Richard A Flavell
Journal:  Nature       Date:  2012-02-01       Impact factor: 49.962

8.  Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients.

Authors:  Hossein Bahrami; Nasser Ebrahimi Daryani; Shahram Mirmomen; Farin Kamangar; Babak Haghpanah; Mehdi Djalili
Journal:  BMC Gastroenterol       Date:  2003-10-16       Impact factor: 3.067

Review 9.  Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies.

Authors:  Mona H Ismail; Massimo Pinzani
Journal:  Hepat Med       Date:  2011-07-04

10.  Nonalcoholic fatty liver disease as an independent risk factor for carotid atherosclerosis.

Authors:  Abid Rasool; Waseem Dar; Muzamil Latief; Imtiyaz Dar; Najeebullah Sofi; Mushtaq Ahmad Khan
Journal:  Brain Circ       Date:  2017-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.